GleanMark

PRE Trademark

PRE is a USPTO trademark filed by Verily Life Sciences LLC. Status: Pending.

Trademark Facts

MarkPRE
Serial Number99291731
StatusPending
Filing Date2025-07-18
Mark TypeWord
Nice Classes009 (Electronics & Software), 038 (Telecommunications), 042 (Software & IT), 044 (Medical Services)
OwnerVerily Life Sciences LLC
Attorney of RecordAndrew T. Pettit
Prosecution Events15
Latest EventNOAM on 2026-04-07

Goods & Services

Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; Downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; Downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; Downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; Downloadable application programming interface (API) software; Downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; Telecommunications services; telecommunications platform related to health; Providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data; healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non\-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields

Recent Prosecution Activity

DateDocumentType
2026-04-07Notice of AllowanceENA
2026-02-10OG Publication ConfirmationPB3
2026-02-04Notice of PublicationPB1
2026-02-04Notification of Notice of PublicationEB4
2026-01-13Amendment and Mail Process CompleteAMC
2026-01-12Response to Office ActionROA

USPTO Refusals on Record

Related